Suspended
PLAIARPlaIaR-Trial: Platelets in Inflammation and Resolution.
What is being collected
Data Collection
Collected from today forward - ProspectiveDNA Samples
Who is being recruted
Blood Platelet Disorders
+ Hematologic Diseases
+ Hemic and Lymphatic Diseases
Over 18 Years
+15 Eligibility Criteria
How is the trial designed
Other
Utilizing specific methods not covered by standard models in order to address unique research questions.Observational
Study Start: May 2021
Summary
Principal SponsorUniversity Hospital Muenster
Study ContactCarola Wempe, DrMore contacts
Last updated: January 28, 2026Sourced from a government-validated database.Claim as a partner
Study start date: May 1, 2021
Actual date on which the first participant was enrolled.Detection and determination of platelets in bronchoalveolar lavage fluid and blood in ARDS and non-ARDS-patients. Correlation with phenotype and inflammation parameters in blood and outcome parameters.
Official TitlePlaIaR-Trial: Platelets in Inflammation and Resolution.
Principal SponsorUniversity Hospital Muenster
Study ContactCarola Wempe, DrMore contacts
Last updated: January 28, 2026Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
72 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other
Some studies use unique or mixed approaches that don't fit standard categories. These may include innovative observational methods or studies tailored to specific research questions.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Conditions
Pathology
Blood Platelet DisordersHematologic DiseasesHemic and Lymphatic Diseases
Criteria
4 inclusion criteria required to participate
Routine bronchoscopy
Patient in perioperative setting
Age >=18 years
Consent
11 exclusion criteria prevent from participating
HIV
Active or recent (in past 7 days) bleeding in upper airways
Recent traumatic injury of the lung associated with (micro-)hemorrhage
Blood aspiration
Show More Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Recruiting
SuspendedOne Study Center